Press Releases

Date Title
08/16/19
Summary ToggleT2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand Printer Friendly Version LEXINGTON, Mass. , Aug. 16, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it entered into an exclusive distribution agreement that allows the Company to
08/14/19
Summary ToggleT2 Biosystems Reports Granting of Inducement Awards Printer Friendly Version LEXINGTON, Mass. , Aug. 14, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on August 1, 2019 it issued inducement awards to five new
08/06/19
Summary ToggleT2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS Printer Friendly Version Designation granted only to new technologies that demonstrate substantial clinical improvement LEXINGTON, Mass. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical
07/30/19
Summary ToggleT2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update Printer Friendly Version Announces Two Financing Agreements to Potentially Provide up to $60 Million of Additional Capital ; Reducing Cash Burn by 30% by Q4 2019 Achieved $1.8 Million in Total Revenue and Secured 12 New T2Dx® Instrument Contracts Updates 2019 Financial Guidance Announced Management Update LEXINGTON, Mass.
07/30/19
Summary ToggleT2 Biosystems to Present at the Canaccord Genuity Growth Conference Printer Friendly Version LEXINGTON, Mass. , July 30, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John Sprague , Chief Financial Officer,
07/26/19
Summary ToggleT2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies Printer Friendly Version Company enters exclusive distribution agreements covering five new markets: Estonia, Greece, Ireland, Saudi Arabia and South Africa LEXINGTON, Mass. , July 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical
07/24/19
Summary ToggleT2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date Printer Friendly Version LEXINGTON, Mass. , July 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019 second quarter financial and operational
07/03/19
Summary ToggleT2 Biosystems Reports Granting of Inducement Awards Printer Friendly Version LEXINGTON, Mass. , July 03, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on July 1, 2019 it issued inducement awards to three new
06/28/19
Summary ToggleT2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts Printer Friendly Version Company ranked #22 on the Boston Business Journal’s annual list of the fastest-growing public companies in Massachusetts LEXINGTON, Mass. , June 28, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in
06/20/19
Summary ToggleT2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019 Printer Friendly Version Real-world data to highlight substantial impact T2Bacteria® has made on patient outcomes LEXINGTON, Mass. , June 20, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare,